Ferozsons Laboratories Limited (PSX:FEROZ)
380.00
-1.07 (-0.28%)
At close: Jul 30, 2026
Ferozsons Laboratories Financials Overview
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 22,677 | 18,857 | 15,855 | 11,457 | 9,330 | 8,879 |
Revenue Growth | 24.85% | 18.93% | 38.38% | 22.80% | 5.08% | 42.93% |
Gross Profit Gross Profit Growth | 10,120 | 7,962 | 6,436 | 4,206 | 3,950 | 3,633 |
Operating Income Operating Income Growth | 2,256 | 1,935 | 1,589 | 949.17 | 1,219 | 1,440 |
Net Income Net Income Growth | 941.68 | 776.54 | 683.15 | 271.27 | 734.43 | 1,173 |
Earnings Per Share EPS Growth | 21.66 | 17.86 | 15.72 | 6.24 | 16.90 | 27.00 |
EPS Growth | 24.97% | 13.67% | 151.84% | -63.06% | -37.41% | 181.42% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Ferozsons Ferozsons Growth | 13,858 | 12,712 | 9,893 | 7,806 | 7,034 |
BF Biosciences BF Biosciences Growth | 5,837 | 3,659 | 1,810 | 1,521 | 1,755 |
Others Others Growth | 809.37 | 604.3 | 459.38 | 368.33 | 395.48 |
Inter-Segment Elimination /Adjustment Inter-Segment Elimination /Adjustment Growth | -1,648 | -1,120 | -705.06 | -365.53 | -304.79 |
Total Total Growth | 18,857 | 15,855 | 11,457 | 9,330 | 8,879 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 1,831 | 2,354 | 1,048 | 1,114 | 2,452 | 2,771 |
Total Debt Total Debt Growth | 4,921 | 4,292 | 4,920 | 3,482 | 2,171 | 1,139 |
Net Cash (Debt) Net Cash Growth | -3,090 | -1,938 | -3,872 | -2,368 | 280.9 | 1,632 |
Net Cash Growth | - | - | - | - | -82.79% | 121.28% |
Net Cash Per Share Net Cash Per Share Growth | -71.09 | -44.59 | -89.08 | -54.47 | 6.46 | 37.55 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 554.04 | 1,436 | -535.33 | -513.85 | 296.92 | 1,816 |
Capital Expenditures CapEx Growth | -1,098 | -663.57 | -544.04 | -2,347 | -1,754 | -1,206 |
Free Cash Flow Free Cash Flow Growth | -544.15 | 771.95 | -1,079 | -2,861 | -1,457 | 609.77 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 44.63% | 42.22% | 40.60% | 36.71% | 42.34% | 40.92% |
Operating Margin | 9.95% | 10.26% | 10.02% | 8.28% | 13.07% | 16.22% |
Pretax Margin | 9.06% | 8.25% | 7.19% | 3.62% | 13.26% | 17.64% |
Profit Margin | 4.15% | 4.12% | 4.31% | 2.37% | 7.87% | 13.22% |
FCF Margin | -2.40% | 4.09% | -6.81% | -24.97% | -15.62% | 6.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.000 | 4.000 | 3.000 | - | 4.167 | 8.333 |
Dividend Per Share Growth | 33.33% | 33.33% | - | - | -50.00% | 200.00% |
Dividend Yield | 1.05% | 1.04% | 1.23% | - | 1.93% | 3.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 17.78 | 21.81 | 15.87 | 21.93 | 13.26 | 10.89 |
Forward PE | - | 9.70 | 9.48 | 9.59 | 9.59 | 9.59 |
P/FCF Ratio | - | 21.94 | - | - | - | 20.96 |
PS Ratio | 0.74 | 0.90 | 0.68 | 0.52 | 1.04 | 1.44 |